PortViewPortView
Bausch Health Companies logo

Bausch Health Companies (BHC) Stock Analysis

NYSEHealthcareDrug Manufacturers - Specialty & Generic

$6.78+7.37%
1-year price historyRange $4.43 – $7.90
52-week range$6.78
$4.33$8.00

Track BHC in your portfolio for free · Portfolio tracker

What Bausch Health Companies does

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Key metrics

Market cap
$2.53B
P/E (TTM)
1.73
EPS (TTM)
$3.92
Beta
0.37
Dividend yield
0.00%
Revenue / share
$28.94
50-day avg
$6.17
200-day avg
$5.69
52-week high
$8.00
52-week low
$4.33
CEO
Thomas J. Appio

ETFs linked to BHC

Broad-market and Healthcare sector ETFs an investor holding Bausch Health Companies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BHC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BHC in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Bausch Health Companies?
Bausch Health Companies trades under the ticker BHC on NYSE.
Which exchange is BHC listed on?
BHC is listed on NYSE.
What sector does Bausch Health Companies operate in?
Bausch Health Companies is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze BHC in a portfolio?
PortView shows BHC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.